VanEck Pharmaceutical ETF (NASDAQ:PPH) Stock Price Down 0.5% – Time to Sell?

VanEck Pharmaceutical ETF (NASDAQ:PPH) traded down 0.5% during mid-day trading on Tuesday . The company traded as low as $110.01 and last traded at $110.53. 97,953 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 308,950 shares. The stock had previously closed at $111.14.

VanEck Pharmaceutical ETF Stock Up 0.9%

The firm has a 50 day moving average of $111.71 and a 200-day moving average of $106.91. The company has a market cap of $1.01 billion, a P/E ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Stockholders of record on Wednesday, July 1st were paid a dividend of $0.6248 per share. The ex-dividend date was Wednesday, July 1st. This represents a $2.50 annualized dividend and a dividend yield of 2.2%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Integrated Wealth Concepts LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at about $78,000. IFP Advisors Inc increased its holdings in VanEck Pharmaceutical ETF by 115.7% during the second quarter. IFP Advisors Inc now owns 537 shares of the company’s stock valued at $59,000 after buying an additional 288 shares during the period. TD Waterhouse Canada Inc. increased its holdings in VanEck Pharmaceutical ETF by 130.0% during the second quarter. TD Waterhouse Canada Inc. now owns 230 shares of the company’s stock valued at $25,000 after buying an additional 130 shares during the period. Continuum Advisory LLC bought a new position in VanEck Pharmaceutical ETF in the second quarter worth approximately $68,000. Finally, Fluent Financial LLC purchased a new stake in VanEck Pharmaceutical ETF during the second quarter worth $4,264,000.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.